Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis

M. bovis strain Bacillus Calmette–Guérin (BCG) has been the only licensed live attenuated vaccine against tuberculosis (TB) for nearly one century and has also been approved as a therapeutic vaccine for bladder cancer treatment since 1990. During its long time usage, different adverse events (AEs) h...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jiangan, Codd, Christopher, Mo, Kevin, He, Yongqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066964/
https://www.ncbi.nlm.nih.gov/pubmed/27749923
http://dx.doi.org/10.1371/journal.pone.0164792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066964/
https://www.ncbi.nlm.nih.gov/pubmed/27749923
http://dx.doi.org/10.1371/journal.pone.0164792

Ejemplares similares